ALIVUS
Invest with MTF
Invest Now
Invest in Alivus Life Sciences with 3.19X leverage
Performance
- Low
- ₹885
- High
- ₹917
- 52 Week Low
- ₹819
- 52 Week High
- ₹1,225
- Open Price₹900
- Previous Close₹899
- Volume79,022
- 50 DMA₹910.54
- 100 DMA₹919.97
- 200 DMA₹944.18
Investment Returns
- Over 1 Month + 0.87%
- Over 3 Month -3.67%
- Over 6 Month -6.91%
- Over 1 Year -13.47%
Smart Investing Starts Here Start SIP with Alivus Life Sciences for Steady Growth!
Alivus Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 20.1
- PEG Ratio
- 0.9
- Market Cap Cr
- 10,924
- P/B Ratio
- 3.6
- Average True Range
- 30.57
- EPS
- 45.82
- Dividend Yield
- 0.6
- MACD Signal
- 5.42
- RSI
- 42.65
- MFI
- 25.25
Alivus Life Sciences Financials
Alivus Life Sciences Technicals
EMA & SMA
Current Price
₹890.00
-9.1
(-1.01%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹913.46
- 50 Day
- ₹910.54
- 100 Day
- ₹919.97
- 200 Day
- ₹944.18
Resistance and Support
897.45
- R3 941.95
- R2 929.60
- R1 909.80
- S1 877.65
- S2 865.30
- S3 845.50
Alivus Life Sciences Corporate Actions - Bonus, Splits, Dividends
Alivus Life Sciences F&O
About Alivus Life Sciences
- NSE Symbol
- ALIVUS
- BSE Symbol
- 543322
- Managing Director & CEO
- Dr. Yasir Rawjee
- ISIN
- INE03Q201024
Similar Stocks to Alivus Life Sciences
Alivus Life Sciences FAQs
Alivus Life Sciences share price is ₹890 As on 19 February, 2026 | 22:21
The Market Cap of Alivus Life Sciences is ₹10923.5 Cr As on 19 February, 2026 | 22:21
The P/E ratio of Alivus Life Sciences is 20.1 As on 19 February, 2026 | 22:21
The PB ratio of Alivus Life Sciences is 3.6 As on 19 February, 2026 | 22:21
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.